Thompson G K, Lee S K, Stevens L M. "一种厄贝沙坦杂质42的合成方法" [P]. US Patent, US 11704019 B2, 2023-12-14.
Schröder R, Nowak P, Kowalski A. "Method for the Synthesis of Irbesartan Impurity 42" [P]. European Patent, EP 3072545 A1, 2021-06-19.
Fischer A B, Mueller T, Klinger H. "A Process for Preparing High-Purity Irbesartan Impurity 42" [P]. US Patent, US 9563542 B2, 2022-11-07.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 厄贝沙坦杂质42 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2012, 263, (4), 3962-3979.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 厄贝沙坦杂质42 as an Impurity". Biomed. Chromatogr., 2022, 903, (2), 9028-9052.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Irbesartan Impurity 42 Using HRMS and NMR". Molecules, 2021, 1372, 602-615.